



HYPERCALCAEMIA AND BONY 
LESIONS IN ASSOCIATION WITH 
PARATHYROID AND PROSTATIC 
CARCINOMA 
F J L K aplan, A B Fataar, N S Levitt 
Parathyroid carcinoma is a rare disease accounting for 0.1 - 5% 
of cases of primary hyperparathyroidism. ') The pre-operative 
differentiation between parathyroid carcinoma and benign 
forms of primary hyperparathyroidism is difficult, as the 
presenting symptoms and signs are similar.' Postoperatively the 
diagnosis may remain unclear as pathological differentiation 
can be equally difficult.' The distinction is, however, important 
as primary hyperparathyroidism due to a benign adenoma has 
an excellent prognosis, while the average survival in a series of 
patients with parathyroid carcinoma was reported to be 40 
months.' Surgical removal of the tumour is at present the only 
effective therapy for parathyroid carcinoma.' 
Primary hyperparathyroidism coexisting with prostatic 
carcinoma has rarely been described,• although it is known that 
there is an increased incidence of gynaecological, thyroid and 
other malignancies in association with primary 
hyperparathyroidism.• As prostatic carcinoma is an unlikely 
cause of hypercalcaemia/ the presence of hypercalcaemia in a 
patient with prostatic carcinoma requires a search for an 
alternative underlying cause. 
We present the first described case of hypercalcaemia 
secondary to parathyroid carcinoma in a patient with prostatic 
carcinoma, and highlight the use of nuclear imaging in 
diagnosis and management. 
CASE REPORT 
A 78-year-old man was referred to the Groote Schuur Hospital 
Endocrine Unit in Feb~ary 1999 for investigation of 
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hypercalcaemia. He had a background of prostatic carcinoma 
diagnosed in 1992 (prostatic specific antigen (PSA) 28 ng/ml, 
normal < 4 ng/ ml), for which conservative treatment was 
recommended. In the same year a diagnosis of primary 
hyperparathyroidism was made, resulting in a 
parathyroidectomy. In addition he had a background of 
hypertension with associated renal impairment, mild cardiac 
failure and duodenal erosion. His medication included 
hydralazine, furosemide, Slow-K and aspirin. 
In November 1998 he was admitted to his local hospital with 
a 1-year history of constipation, and was found to have faecal 
impaction. A baritun enema was normal and he was treated 
with laxatives. He also complained of 3- 4 months of pain in 
the left knee. A radiograph of the knee revealed a lytic lesion of 
the tibial plateau (Fig. 1) and a serum calcium level was found 
to be 3.63 rrunol/1 (normal 2 .1 - 2.6 rrunol/1). The urea level was 
11 rnmo]/1 and the creatinine level 319 fllilOl/1. A diagnosis of 
metastatic prostatic carcinoma resulting in hypercalcaemia was 
considered, but thought to be unlikely as the tibial lesion was 
ly tic rather than sclerotic. The patient was therefore referred to 
us with possible primary hyperparathyroidism. 
Fig. 1. Radiograph of the left knee showing a lytic lesion involving the 
lateral aspect of the tibial plateau. 
At presentation to our clinic, his symptoms included a 27 kg 
weight loss over 1 year, progressive weakness, polydipsia, cold 
intolerance, dryness of the skin, insomnia and according to his 
daughter, occasional confusion. He also complained of 
vomiting which was responsive to cirnetidine. There was no 
history of renal stones. On examination the patient appeared 
remarkably well and gave a good account of himself. The 
salient clinical findings were pallor, no lymphadenopathy, a 
parathyroidectomy scar, absence of a neck mass, h ypertension, 
a mildly distended abdomen with palpable faecal loading, mi]d 
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proximal myopathy, delayed relaxation of the deep tendon 
reflexes and tenderness over the left proximal tibia. A rectal 
examination was refused. 
The primary diagnosis was recurrence of his primary 
hyperparathyroidism with a brown tumour of the left tibial 
plateau. In addition there was clinical evidence of 
hypothyroidism. The results of biochemical investigations 
were: serum calcium 3.63 mmol/1 (corrected for the albumin of 
47 g/ 1), phosphate 1.47 mmol/ 1 (normal 0.8 - 1.4 mmol/1), urea 
17 rnmol/1, creatinine 345 ].lllOl/1, magnesium 0.9 rnmol/1 
(normal 0.7 -1.0 mmol/ 1), alkaline phosphatase 115 U / l 
(normal 30 - 70 U / l), parathyroid hormone level (PTH) 1 742 
pg/rnl (norrnal12- 72 pg/ rnl), serum protein electrophoresis 
negative and PSA 71 ng/ rnl. The phosphate level was relatively 
low for the degree of renal impairment, supporting a diagnosis 
of primary rather than tertiary hyperparathyroidism. 
Assessment of thyroid function and the hypothalarno-pituitary-
gonadal axis demonstrated evidence of sick euthyroid and sick 
gonadotroph syndromes, with normal prolactin and gastrin 
levels. The radiograph of his knee revealed a lytic lesion 
involving the lateral aspect of the left tibial plateau as well as 
smaller lesions involving the distal femoral shaft and proximal 
fibular shaft (Fig. 1). Diffuse osteopenia was evident on the 
skull radiograph and the chest radiograph revealed normal 
heart and lungs. A radiograph of his hands showed 
subperiostial resorption and lesions compatible with brown 
tumours involving the left third metacarpal and proximal 
phalanx, and the proximal phalanx of the left thumb (Fig. 2). A 
whole-body Tc99m MDP bone scan revealed a 'super' bone scan 
compatible with a metabolic disorder together w ith areas of 
increased uptake involving the left lateral tibial plateau as well 
as the hands, ribs, pelvis and left femur. 
Fig. 2. Radiograph of the left hand showing subperiostia/ resorption 
and lesions compatible with brown tumours involving the third 
metacarpal and proximal phalanx, and the proximal phalanx of the 
thumb. 
Tc99m sestarnibi parathyroid scan showed two areas of 
abnormally hyperfunctioning tissue in the region of the right 
lower pole of the thyroid and another just inferior to that area, 
compatible with hyperfunctioning parathyroid tissue (Fig. 3). 
The patient was referred for parathyroidectomy. Histological 
examination revealed a right inferior parathyroid gland 
neoplasm but it was unclear whether this was benign or 
malignant. Postoperatively the PTH and calcium levels 
remained persistently elevated at 1 045 pg/ rnl and 3.1 mmol/1 
respectively, while the sick euthyroid and gonadotroph 
syndromes resolved without replacement therapy. 
Fig. 3. Tc99m sestamibi parathyroid scan showing two areas of 
abnormally hyperfunctioning tissue in the region of the right lower 
pole of the thyroid and another just inferior to that area. 
Further investigations were requested. Repeat sestarnibi scan 
revealed an area of abnormally increased uptake below the 
r ight thyroid lobe. This correla ted with a 1.5 em soft-tissue 
mass in the right para tracheal region below the lower pole of 
the right thyroid lobe extending over a length of 3 em, seen on 
computed tomography (CT) scan. The patient underwent 
repeat parathyroidectomy 4 mon ths after the first proced ure. 
On this occasion an adenocarcinoma of the right inferior 
parathyroid gland was diagnosed on histological examination. 
Postoperatively the serum calcium level fell to 1.65 mmol/1 
and the PTH to 256 pg/ml. The patient was treated w ith oral 
calcium and 1-alpha-hydroxycholecalciferol in anticipation of 
the increased calcium requirement during skeletal 
remineralisation for at least a year postoperatively. At his last 
follow-up visit 3 months post<.peratively the patient's calcium 
level was 2.33 mmol/1 and his phosphate levell.31 mmol/1, 
and he felt remarkably well with minimal knee pain. A repeat 
radiograph of the knee showed filling of the previously lucent 
area (Fig. 4). Osteodensitometry demonstrated osteoporosis of 
the left hip (T-score -2.93 at the neck of femur), and osteopenia 
of the lumbar spine (T-score -2.22 at L 1-4), compatible with 
hyperparathyroidism in which the resorption of cortical bone 
exceeds that of cancellous bone. The case has been reviewed by 
the urologists who have recommended conservative treatmen t 
for the prostatic carcinoma. Fu ture plans include repeat 
osteodensitometry in 1 year, as well as monitoring of the 
calcium level in view of the possibility of recurrence of 
parathyroid carcinoma. 
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Fig. 4. Repeat radiograph of the left knee showing filling of the 
previously lucent area involving the tibial plateau. 
D ISCUSSION 
Parathyroid carcinoma is a rare cause of primary 
hyperparathyroidism and is difficult to distinguish from 
benign forms of hyperparathyroidism . It should be suspected 
in hyperparathyroid patien ts with serum calcium levels > 3.5 
mmol/1, markedly elevated PTH levels, a palpable neck mass, 
pre-operative imaging showing a tumour measuring 3 em or 
more and recurrence of previously treated primary 
hyperparathyroidism. t s Cordeiro et a/. 1 reported a series of 
cases with parathyroid carcinoma where PTH levels varied 
from 1.03 to 16.5 times the upper limit of the normal range, 
with an average of 7.2 times. Our patien t had all of the above 
features: serum PTH 27 times the upper limit of normal, serum 
calcium 3.63 mmol/1, tumour size 3 em before final surgery, 
and a history of previous parathyroidectomy. Ultimately, 
however, the diagnosis of malignancy depends on pathological 
evaluation and may only become apparent after the recurrence 
of a previously resected 'parathyroid adenoma', as in our case.' 
Parathyroid carcinoma in a patient with prostatic carcinoma 
has not previously been described. The patient was initially 
thought to have metastatic prostatic carcinoma resulting in 
hypercalcaemia. Hypercalcaemia secondary to prostatic 
carcinoma is, however, extremely rare, typically occurring with 
ad vanced disease and widespread metastases.•·• In contrast, 
hypercalcaemia is almost invariably present in parathyroid 
carcinoma, as non-functioning tumours are rare.10•11 There are a 
number of arguments against prostatic carcinoma as a cause for 
the bony lesions in our patient, including their lytic rather than 
sclerotic appearance and the distribution depicted on the Tc99m 
MDP bone scan. Brown tumours classically involve the facial 
bones, hands, pelvis, ribs and femurs/ 2 while prostatic 
carcinoma typically metastasises to the spine where increased 
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osteoblastic activity results in the formation of new sclerotic 
bone.13 
Nuclear imaging was particularly useful in our case, not only 
to demonstrate the brown tumours but also for localisation of 
the parathyroid tumour. Although surgical success in primary 
intervention for primary hyperparathyroidism exceeds 90% 
without localisation studies, localisation tests are essential for 
re-exploration. The sestarnibi scan appears to be the most 
sensitive and accurate non-invasive test available today.14 
Evidence suggests similar behaviour of parathyroid carcinoma 
and adenoma in technetium-MIBI scintigraphy.1'-17 The sestarnibi 
scan w as used successfully in this patient to localise the tumour 
and guide surgery. Brown tumours may not only be detected, 
but also effectively followed up using sestarnibi scintigraphy." 
This patient underwent limited-body sestarnibi imaging which 
revealed areas of increased uptake corresponding to the brown 
tumours seen on plain radiography. It may be anticipated that 
these areas will disappear when repeat imaging is performed 9 
months after successful treatment of~ hyperparathyroidism. 
The whole-body Tc99m MDP bone scan could be used to 
monitor the response to surgery but could remain positive for 
up to a year postoperatively. 
In view of the diverse biological behaviour reported for 
parathyroid carcinoma, prediction of prognosis for this patient 
is difficult. Long disease-free periods after surgery may 
precede recurrence, with shorter time intervals after repeated 
surgery.' Mortality is related mainly to the inabili ty to control 
hypercalcaemia.19 This patient's serum calcium level will 
therefore be closely monitored and repeat surgery considered 
in the event of recurrence. 
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